Engineering improved variants of the antifungal peptide histatin 5 with reduced susceptibility to Candida albicans secreted aspartic proteases and enhanced antimicrobial potency
PublisherBlackwell Publishing Ltd
MetadataShow full item record
AbstractCandida albicans is an opportunistic fungal pathogen and a commensal organism that commonly colonizes mucosal surfaces, including those inside the human mouth. To help control C. albicans, human saliva contains the antifungal peptide histatin 5 (Hst-5), which has strong antifungal activity against C. albicans. However, the pathogen produces secreted aspartic proteases (Saps) that cleave Hst-5 at lysine residues and eliminate its antifungal properties. We designed variants of Hst-5 with its lysine residues substituted with arginine or leucine to evaluate the effect on proteolysis by Saps. We found site-, residue-, and Sap-dependent effects from single amino acid substitutions. The K17R and K17L modifications led to dramatic results, with over 77% and 100% intact peptide remaining after incubation with Sap9 and Sap2, respectively, compared to 47% and 61% of Hst-5. This decrease in proteolysis was accompanied by a reduction in cleavage on the C-terminal side of K17, suggesting the Saps prefer lysine at K17 for cleavage. Incubation with C. albicans cells and culture supernatant corroborated the results with purified Saps and highlighted their biological relevance. The modifications to Hst-5 do not diminish the antifungal activity of Hst-5, and, in fact, the K17R, K17L, and K11R peptides retained significantly more antifungal activity after treatment with Saps than Hst-5. Our results indicate that single amino acid modifications drastically impact both proteolysis at the modification sites and the overall level of proteolysis of the peptide, demonstrating the potential of designing peptides for resistance to proteolysis as a means for improving therapeutic efficacy. Copyright 2017 Federation of European Biochemical Societies
SponsorsWe thank Bernhard Hube for providing the purified Saps. This work was supported by a National Institutes of Health training grant in Host-Pathogen Interactions (T32AI089621B) and a University of Maryland Cross-Campus Seed Grant.
Identifier to cite or link to this itemhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85036546240&doi=10.1111%2ffebs.14327&partnerID=40&md5=217b25bc940f7eda8a1400e6c5c538c1; http://hdl.handle.net/10713/9110
- Histatin 5 variant reduces Candida albicans biofilm viability and inhibits biofilm formation.
- Authors: Moghaddam-Taaheri P, Leissa JA, Eppler HB, Jewell CM, Karlsson AJ
- Issue date: 2021 Apr
- Effects of histatin 5 modifications on antifungal activity and kinetics of proteolysis.
- Authors: Ikonomova SP, Moghaddam-Taaheri P, Wang Y, Doolin MT, Stroka KM, Hube B, Karlsson AJ
- Issue date: 2020 Feb
- The action of ten secreted aspartic proteases of pathogenic yeast Candida albicans on major human salivary antimicrobial peptide, histatin 5.
- Authors: Bochenska O, Rapala-Kozik M, Wolak N, Aoki W, Ueda M, Kozik A
- Issue date: 2016
- Evaluation of the Antifungal and Wound-Healing Properties of a Novel Peptide-Based Bioadhesive Hydrogel Formulation.
- Authors: Sultan AS, Vila T, Hefni E, Karlsson AJ, Jabra-Rizk MA
- Issue date: 2019 Oct
- Inactivation of the antifungal and immunomodulatory properties of human cathelicidin LL-37 by aspartic proteases produced by the pathogenic yeast Candida albicans.
- Authors: Rapala-Kozik M, Bochenska O, Zawrotniak M, Wolak N, Trebacz G, Gogol M, Ostrowska D, Aoki W, Ueda M, Kozik A
- Issue date: 2015 Jun